Validation of a Quick Flow Cytometry-Based Assay for Acute Infection Based on CD64 and CD169 Expression. New Tools for Early Diagnosis in COVID-19 Pandemic

Validation of a Quick Flow Cytometry-Based Assay for Acute Infection Based on CD64 and CD169 Expression. New Tools for Early Diagnosis in COVID-19 Pandemic

Objectives: Several parameters aid in deciphering between viral and bacterial infections; however, new tools should be investigated in order to reduce the time to results and proceed with an early target-therapy. Validation of a biomarker study, including CD64 and CD169 expression, was conducted.Mat...

Full description

Bibliographic Details
Main Authors: Alejandra Comins-Boo, Maria Gutiérrez-Larrañaga, Adriel Roa-Bautista, Sandra Guiral Foz, Mónica Renuncio García, Elena González López, Juan Irure Ventura, María Carmen Fariñas-Álvarez, David San Segundo, Marcos López Hoyos
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-03-01
Series:Frontiers in Medicine
Subjects:
biomarkers
flow cytometry
validation
CD169
CD64
SARS-CoV-2
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2021.655785/full

Internet

https://www.frontiersin.org/articles/10.3389/fmed.2021.655785/full

Similar Items